[go: up one dir, main page]

DD236522A5 - Verfahren zur herstellung medizinisch wertvoller verbindungen und zwischenverbindungen - Google Patents

Verfahren zur herstellung medizinisch wertvoller verbindungen und zwischenverbindungen Download PDF

Info

Publication number
DD236522A5
DD236522A5 DD85280184A DD28018485A DD236522A5 DD 236522 A5 DD236522 A5 DD 236522A5 DD 85280184 A DD85280184 A DD 85280184A DD 28018485 A DD28018485 A DD 28018485A DD 236522 A5 DD236522 A5 DD 236522A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
radical
compounds
reaction
Prior art date
Application number
DD85280184A
Other languages
German (de)
English (en)
Inventor
Geoffrey Allan
Donald Bull
George W Hardy
Grahame R Lee
Original Assignee
The Wellcome Foundation Limited,Gb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wellcome Foundation Limited,Gb filed Critical The Wellcome Foundation Limited,Gb
Publication of DD236522A5 publication Critical patent/DD236522A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD85280184A 1984-09-01 1985-08-30 Verfahren zur herstellung medizinisch wertvoller verbindungen und zwischenverbindungen DD236522A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848422165A GB8422165D0 (en) 1984-09-01 1984-09-01 Compounds

Publications (1)

Publication Number Publication Date
DD236522A5 true DD236522A5 (de) 1986-06-11

Family

ID=10566163

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85280184A DD236522A5 (de) 1984-09-01 1985-08-30 Verfahren zur herstellung medizinisch wertvoller verbindungen und zwischenverbindungen

Country Status (16)

Country Link
EP (1) EP0174162A3 (fr)
JP (1) JPS6183198A (fr)
KR (1) KR860002501A (fr)
AU (1) AU581455B2 (fr)
CS (1) CS621585A2 (fr)
DD (1) DD236522A5 (fr)
DK (1) DK396885A (fr)
ES (6) ES8703418A1 (fr)
FI (1) FI853336L (fr)
GB (1) GB8422165D0 (fr)
GR (1) GR852113B (fr)
HU (1) HUT39190A (fr)
MC (1) MC1695A1 (fr)
PL (3) PL265523A1 (fr)
PT (1) PT81055B (fr)
ZA (1) ZA856672B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT46045A (en) * 1986-02-28 1988-09-28 Wellcome Found Process for producing new compounds and pharmaceutics comprising same
EP0237239A3 (fr) * 1986-02-28 1988-08-17 The Wellcome Foundation Limited Composés
US5036051A (en) * 1987-10-06 1991-07-30 Abbott Laboratories Glaucoma treatment
US4927807A (en) * 1987-10-06 1990-05-22 Abbott Laboratories Glaucoma treatment
US5346887A (en) * 1987-10-06 1994-09-13 Abbott Laboratories Glaucoma treatment
US5187183A (en) * 1988-06-15 1993-02-16 Brigham & Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
US5025001A (en) * 1988-06-15 1991-06-18 Brigham And Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
US5356890A (en) * 1988-06-15 1994-10-18 Brigham And Women's Hospital S-nitroso derivatives of ace inhibitors and the use thereof
US5059589A (en) * 1988-09-08 1991-10-22 Abbott Laboratories Glaucoma treatment
US4916129A (en) * 1989-01-19 1990-04-10 E. I. Du Pont De Nemours And Company Combination β-blocking/angiotensin II blocking antihypertensives
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
US10166381B2 (en) 2011-05-23 2019-01-01 Excelsior Medical Corporation Antiseptic cap
EP2731658B1 (fr) 2011-07-12 2020-04-01 Pursuit Vascular, Inc. Dispositif de distribution d'agent antimicrobien dans cathéter transdermique
WO2015168677A1 (fr) 2014-05-02 2015-11-05 Excelsior Medical Corporation Emballage de bande pour bouchon antiseptique
AU2016262400B2 (en) 2015-05-08 2021-01-21 Icu Medical, Inc. Medical connectors configured to receive emitters of therapeutic agents
EP4194043A1 (fr) 2016-10-14 2023-06-14 ICU Medical, Inc. Capuchons désinfectants pour raccords médicaux
WO2018204206A2 (fr) 2017-05-01 2018-11-08 Icu Medical, Inc. Raccords de fluide médical et procédés pour fournir des additifs dans des conduites de fluide médical
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
WO2020106985A1 (fr) 2018-11-21 2020-05-28 Pursuit Vascular, Inc. Dispositif antimicrobien comprenant un capuchon avec bague et insert
JP2024500319A (ja) 2020-12-07 2024-01-09 アイシーユー・メディカル・インコーポレーテッド 腹膜透析キャップ、システム、及び方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3705907A (en) * 1970-02-19 1972-12-12 Sandoz Ltd 4-(2-hydroxy)-3-aminopropoxy)-indole derivatives
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
DE3177130D1 (de) * 1980-08-30 1990-01-11 Hoechst Ag Aminosaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung.
GR75019B (fr) * 1980-09-17 1984-07-12 Univ Miami
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4462943A (en) * 1980-11-24 1984-07-31 E. R. Squibb & Sons, Inc. Carboxyalkyl amino acid derivatives of various substituted prolines
EP0080822A1 (fr) * 1981-11-27 1983-06-08 Beecham Group Plc Peptides issus de prolinol, à activité anti-hypertensive
IE55867B1 (en) * 1981-12-29 1991-02-14 Hoechst Ag New derivatives of bicyclic aminoacids,processes for their preparation,agents containing these compounds and their use,and new bicyclic aminoacids as intermediates and processes for their preparation
DE3360065D1 (en) * 1982-03-08 1985-03-28 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
EP0099709A3 (fr) * 1982-07-19 1985-11-13 Imperial Chemical Industries Plc Dérivés d'amide

Also Published As

Publication number Publication date
ES8801672A1 (es) 1988-02-16
PL265523A1 (en) 1988-02-04
ES553610A0 (es) 1988-01-01
ES553614A0 (es) 1988-02-16
EP0174162A2 (fr) 1986-03-12
ES8801313A1 (es) 1988-01-01
EP0174162A3 (fr) 1988-07-27
KR860002501A (ko) 1986-04-26
ZA856672B (en) 1987-05-27
ES8801312A1 (es) 1987-12-16
PT81055A (en) 1985-09-01
AU4693285A (en) 1986-03-06
ES553613A0 (es) 1988-01-01
HUT39190A (en) 1986-08-28
PL265522A1 (en) 1988-05-12
FI853336L (fi) 1986-03-02
ES8703418A1 (es) 1987-02-16
AU581455B2 (en) 1989-02-23
ES8801310A1 (es) 1988-01-01
PT81055B (en) 1987-07-02
ES546595A0 (es) 1987-02-16
ES553612A0 (es) 1987-12-16
PL255192A1 (en) 1987-09-21
GB8422165D0 (en) 1984-10-03
JPS6183198A (ja) 1986-04-26
DK396885D0 (da) 1985-08-30
GR852113B (fr) 1985-12-24
FI853336A0 (fi) 1985-08-30
DK396885A (da) 1986-03-02
ES8801311A1 (es) 1987-12-16
MC1695A1 (fr) 1986-07-18
ES553611A0 (es) 1987-12-16
CS621585A2 (en) 1989-08-14

Similar Documents

Publication Publication Date Title
DD236522A5 (de) Verfahren zur herstellung medizinisch wertvoller verbindungen und zwischenverbindungen
DE69418083T2 (de) Verbindungen mit eine Sulfonamid- und einer Amidinogruppe, ihr Herstellungsverfahren und sie enthaltende pharmazeutische Zubereitungen
EP0094095B1 (fr) Acides carboxyliques bicycliques et leurs esters alkyliques et aralkyliques
DE69019481T2 (de) Aminosäurederivate.
EP0089637B1 (fr) Dérivés d'amino acides bicycliques, procédé pour leur préparation, agents les contenant et leur utilisation, ainsi que des amino acides bicycliques comme produits intermédiaires et procédé pour leur préparation
EP0119161B1 (fr) Dérivés de benzazocinone et benzazoninon, leur procédé de préparation, préparations pharmaceutiques contenant ces composés, et leur application thérapeutique
EP0084164A2 (fr) Dérivés d'amino-acides bicycliques, procédé pour leur préparation, agents les contenant et leur utilisation ainsi que des amino-acides bicycliques comme intermédiaires et procédé pour leur préparation
DD284222A5 (de) Verfahren zur herstellung von cycloalkylsubstituierten glutaramidderivaten
DD202546A5 (de) Verfahren zur herstellung von neuen benzapetin-2-onen
DE19510566A1 (de) Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0079022A2 (fr) Dérivés de l'acide cis, endo-2-azabicyclo-(3.3.0)-octane-3-carboxylique, procédé pour leur préparation, medicaments les contenant et leur application
EP0111873A1 (fr) Dérivés de l'acide cis, endo-aza-2 bicyclo(5.3.0)décane-carboxylique-3, procédé pour leur préparation, compositions les contenant et leur application
DE3508251A1 (de) Dipeptide
DE2856753A1 (de) N-substituierte omega -aminoalkanoyl- omega -aminoalkansaeuren, ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
EP0796271B1 (fr) p-amidinobenzylamides dipeptidiques a restes n-terminaux sulfonyle ou aminosulfonyle
EP0105102A1 (fr) Dérivés d'acides 2-aza-bicyclo(2,2,2)-octane-3-carboxyliques, leur procédé de préparation, les médicaments les contenant et leur application, ainsi que l'acide 2-aza-bicyclo(2,2,2)-octane-3-carboxylique comme intermédiaire et le procédé pour sa préparation
DE3606448A1 (de) Aminoalkanoylureidoamino- und -iminosaeure-verbindungen
EP0222283B1 (fr) Dérivés d'acides aminés
EP0233483B1 (fr) Pyrrolo[1,2-a][4,1]benzoxazépines, procédé pour leur préparation, compositions pharmaceutiques contenant ces composés et application therapeutique
DE2112057A1 (de) Neue Penicillinester
EP0113880A2 (fr) Derivés de 2-azabicyclo(2.2.1)heptane, leur procédé de préparation, les composés les contentant et leur emploi, de même que les dérivés de 2-azabicyclo(2.2.1)heptane comme intermédiaires et leur procédé de préparation
EP0203450B1 (fr) Dérivés d'amino-acides bicycliques, leur procédé de préparation, les agents les contenant et leur emploi
DE3701209C2 (fr)
DD206553A5 (de) Verfahren zur herstellung von tripeptiden
EP0069894B1 (fr) Dipeptides optiquement actives, sels du même pharmaceutiquement acceptables, procédé de leur préparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee